Help Shape the Future of CML Care – Take Part in Our International Survey
Are you living with Chronic Phase Chronic Myeloid Leukemia (CP-CML) Your voice can make a difference!
We are inviting you to take part in a pioneering global study to better understand what truly matters to patients when choosing treatments.
By participating in a 20-30 minute anonymous online survey, you can help influence how future treatments are developed and how treatment decisions are made — – ensuring they reflect real patient needs and preferences.
Purpose of the Study
This patient-led study is designed to uncover which characteristics of CML treatments are most important to people living with CP-CML. Your input will support more patient-centered, ethical, and effective care worldwide.
Who Can Take Part?
You may be eligible if you:
- Are 18 years or older
- Have been diagnosed with Ph+ CP-CML
- Are currently on a TKI (first, second, or third line) for 90 days or more, or are newly diagnosed and treatment-naïve
- Live in the UK, US, Canada, France, Germany, Italy, Spain, China, or Japan
What’s Involved?
Participants will:
- Complete a series of 12 discrete choice experiments, selecting between hypothetical treatment options
- Share some basic demographic information
- Spend approximately 20–30 minutes on the survey
Your participation is completely anonymous, and your responses will directly contribute to improving the lives of others living with CML.
Questions?
Please contact Anastasia at anastasia@cmladvocates.net.
